3rd July 2020
- 0 comments
Nanotechnology business, MIP Diagnostics, has completed a £5.1m funding round to accelerate its global expansion. The co-investment has come from Mercia Asset Management, a founding investor and the largest shareholder in the company, and was led by Downing Ventures (£1.4m), BGF (£2m) and Calculus Capital.
...In order to read the full story we need you to be registered with us, please click the links below to login or register.